“An inspiring conference with ample opportunity to mix with people with other areas of expertise. Thanks Phacilitate for pulling it off again!”

Professor Ben van der Zeijst, Scientific Director, Netherlands Vaccine Institute

"Great content and venue. High quality of participants and presenters, and great diversity of topics"

Aline Seilly, Field Marketing Manager, EU, Millipore

"Very good meeting overall – a broad spectrum of topics was covered and brilliant speakers were present. Very well organised"

Hedwig Kresse, Senior Analyst, Infectious Diseases, Datamonitor plc

"Good balance between industry and public sector. Outstanding organisation and excellent networking opportunities"

Hilde de Winter, Medical Director, GENimmune

"Excellent agenda, venue and networking opportunity"

Drew Hannaman, Vice President, R&D, Ichor Medical Systems, Inc

“Combining the active immunotherapy forum with the vaccine forum provided a good opportunity to learn from these complimentary research areas and share ideas”

Dr Laura Aguilar, Vice President, Clinical Research, Advantagene

"I found this a really interesting mix of topics and speakers, giving a very broad perspective. The speakers were present and accessible!"

Dr Robert Burns, CEO, Alvos Oncology

"Very interesting and multi-angled symposium, allowing stimulating discussion and new ideas"

Dr Frank Vandendriessche, Director, Regulatory Affairs Europe, Vaccines/Biologics, Merck Sharp & Dome (Europe) Inc

"The Phacilitate Vaccine Forum offers a great mix of regulators, industry and academia. Locations are always excellent"

Dr Roeland van Dam, Marketing & Business Development, Netherlands Vaccine Institute